These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29433571)

  • 1. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
    Tetzlaff MT; Nelson KC; Diab A; Staerkel GA; Nagarajan P; Torres-Cabala CA; Chasen BA; Wargo JA; Prieto VG; Amaria RN; Curry JL
    J Immunother Cancer; 2018 Feb; 6(1):14. PubMed ID: 29433571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
    Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
    Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.
    Chen WS; Tetzlaff MT; Diwan H; Jahan-Tigh R; Diab A; Nelson K; Glitza IC; Kaunitz GJ; Johnson D; Torres-Cabala C; Pacha O; Taube JM; Maloney K; Prieto VG; Curry JL
    J Cutan Pathol; 2018 Oct; 45(10):764-773. PubMed ID: 29943453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.
    Danlos FX; Pagès C; Baroudjian B; Vercellino L; Battistella M; Mimoun M; Jebali M; Bagot M; Tazi A; Lebbé C
    Chest; 2016 May; 149(5):e133-6. PubMed ID: 27157227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
    Woodbeck R; Metelitsa AI; Naert KA
    Am J Dermatopathol; 2018 Jul; 40(7):523-526. PubMed ID: 29924748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I; Malinzak M; Salama AKS
    J Immunother Cancer; 2018 Jul; 6(1):77. PubMed ID: 30064495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
    Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
    Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
    Firwana B; Ravilla R; Raval M; Hutchins L; Mahmoud F
    J Oncol Pharm Pract; 2017 Dec; 23(8):620-624. PubMed ID: 27590328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings.
    Cervantes J; Rosen A; Dehesa L; Dickinson G; Alonso-Llamazares J
    Actas Dermosifiliogr (Engl Ed); 2019; 110(1):43-49. PubMed ID: 30389125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.
    Cao Y; Afzal MZ; Gutmann EJ; Shirai K
    Melanoma Res; 2024 Feb; 34(1):70-75. PubMed ID: 37830935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.
    Trinidad C; Nelson KC; Glitza Oliva IC; Torres-Cabala CA; Nagarajan P; Tetzlaff MT; Ivan D; Hwu WJ; Prieto VG; Curry JL; Aung PP
    J Cutan Pathol; 2018 Jul; 45(7):504-507. PubMed ID: 29633300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoid-like reactions in patients receiving modern melanoma treatment.
    Dimitriou F; Frauchiger AL; Urosevic-Maiwald M; Naegeli MC; Goldinger SM; Barysch M; Franzen D; Kamarachev J; Braun R; Dummer R; Mangana J
    Melanoma Res; 2018 Jun; 28(3):230-236. PubMed ID: 29485531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.
    Chanson N; Ramos-Casals M; Pundole X; Suijkerbuijk K; José de Barros E Silva M; Lidar M; Benesova K; Leipe J; Acar-Denizli N; Pradère P; Michot JM; Voisin AL; Suárez-Almazor ME; Radstake TRD; Fernandes Moça Trevisani V; Schulze-Koops H; Melin A; Robert C; Mariette X; Baughman RP; Lambotte O; ; ; ; ; ;
    Eur J Cancer; 2021 Nov; 158():208-216. PubMed ID: 34452793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission.
    Yatim N; Mateus C; Charles P
    Rev Med Interne; 2018 Feb; 39(2):130-133. PubMed ID: 29277453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab.
    González-Cruz C; Bodet D; Muñoz-Couselo E; García-Patos V
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
    Jespersen H; Bjursten S; Ny L; Levin M
    Lancet Oncol; 2018 Jun; 19(6):e327. PubMed ID: 29893264
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-induced cutaneous sarcoidosis in melanoma.
    Suárez-García C; Pérez-Gil A; Pereira-Gallardo S; Codes-Villena M; García-Escudero A; Miguel Camacho F
    Melanoma Res; 2009 Dec; 19(6):391-4. PubMed ID: 19770687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in sarcoidosis and sarcoid-like reactions associated to immune checkpoint inhibitors: A narrative review apropos of a case.
    Apalla Z; Kemanetzi C; Papageorgiou C; Bobos M; Manoli M; Fotiadou C; Hatzibougias D; Boukovinas I; Stergiou E; Levva S; Lallas A; Lazaridou E
    Dermatol Ther; 2021 Jan; 34(1):e14618. PubMed ID: 33263945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoid-like reaction in cases treated by checkpoint inhibitors.
    Paydas S
    Med Oncol; 2021 Feb; 38(3):29. PubMed ID: 33598792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of granuloma annulare under anti-PD1 therapy].
    Charollais R; Aubin F; Roche-Kubler B; Puzenat E
    Ann Dermatol Venereol; 2018 Feb; 145(2):116-119. PubMed ID: 29221649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.